Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Recruiting · NCT05808634 · Registry updated 2025-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma. | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 1 | 2025-09-25 | NCT05808634 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BioAtla, Inc. | 3 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fred Hutch Cancer Center | Seattle | United States | 12 |
| Karmanos Cancer Institute | Detroit | United States | 153 |
| Northwestern University | Chicago | United States | 727 |
| The Christ Hospital Cancer Center | Cincinnati | United States | 8 |
| UC Irvine | Irvine | United States | 3 |
| University Hospitals Cleveland Medical Center | Cleveland | United States | 234 |
| University of Illinois | Chicago | United States | 238 |
| Usc Norris Comprehensive Cancer Center | Los Angeles | United States | 67 |
| Yale Cancer Center | New Haven | United States | 21 |